Sutro Biopharma (STRO) Leases (2021 - 2025)
Historic Leases for Sutro Biopharma (STRO) over the last 5 years, with Q3 2025 value amounting to $13.3 million.
- Sutro Biopharma's Leases fell 2988.38% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year decrease of 2988.38%. This contributed to the annual value of $17.7 million for FY2024, which is 2252.03% down from last year.
- According to the latest figures from Q3 2025, Sutro Biopharma's Leases is $13.3 million, which was down 2988.38% from $14.8 million recorded in Q2 2025.
- Sutro Biopharma's 5-year Leases high stood at $30.1 million for Q3 2021, and its period low was $13.3 million during Q3 2025.
- For the 5-year period, Sutro Biopharma's Leases averaged around $22.9 million, with its median value being $24.0 million (2023).
- Per our database at Business Quant, Sutro Biopharma's Leases plummeted by 894.6% in 2022 and then plummeted by 2988.38% in 2025.
- Over the past 5 years, Sutro Biopharma's Leases (Quarter) stood at $29.0 million in 2021, then dropped by 8.95% to $26.4 million in 2022, then fell by 13.72% to $22.8 million in 2023, then fell by 22.52% to $17.7 million in 2024, then fell by 24.53% to $13.3 million in 2025.
- Its last three reported values are $13.3 million in Q3 2025, $14.8 million for Q2 2025, and $16.3 million during Q1 2025.